Does APIXABAN Cause Embolism arterial? 23 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Embolism arterial have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
23
Reports of Embolism arterial with APIXABAN
0.0%
of all APIXABAN reports
2
Deaths
15
Hospitalizations
How Dangerous Is Embolism arterial From APIXABAN?
Of the 23 reports, 2 (8.7%) resulted in death, 15 (65.2%) required hospitalization, and 10 (43.5%) were considered life-threatening.
Is Embolism arterial Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Embolism arterial?
DROSPIRENONE\ETHINYL ESTRADIOL (235)
BEVACIZUMAB (63)
CISPLATIN (36)
FLUOROURACIL (34)
OXALIPLATIN (28)
CARBOPLATIN (25)
PEMBROLIZUMAB (23)
DABIGATRAN ETEXILATE (22)
ETHINYL ESTRADIOL\ETONOGESTREL (20)
RIVAROXABAN (20)
Which APIXABAN Alternatives Have Lower Embolism arterial Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ